Cargando…

Cell Reprogramming in Tumorigenesis and Its Therapeutic Implications for Breast Cancer

Breast cancer is the most common malignancy in women worldwide and can be categorized into several subtypes according to histopathological parameters or genomic signatures. Such heterogeneity of breast cancer can arise from the reactivation of mammary stem cells in situ during tumorigenesis. Moreove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chu, Pei-Yi, Hou, Ming-Feng, Lai, Ji-Ching, Chen, Long-Fong, Lin, Chang-Shen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515165/ https://www.ncbi.nlm.nih.gov/pubmed/31013830 http://dx.doi.org/10.3390/ijms20081827

Ejemplares similares

Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications
por: Gandhi, Nishant, et al.
Publicado: (2019)

EBV Infection and Its Regulated Metabolic Reprogramming in Nasopharyngeal Tumorigenesis
por: Yang, Tingting, et al.
Publicado: (2022)

Leukemia inhibitory factor drives glucose metabolic reprogramming to promote breast tumorigenesis
por: Yue, Xuetian, et al.
Publicado: (2022)

Pathological implications of metabolic reprogramming and its therapeutic potential in medulloblastoma
por: Marabitti, Veronica, et al.
Publicado: (2022)

p53 connects tumorigenesis and reprogramming to pluripotency
por: Tapia, Natalia, et al.
Publicado: (2010)

EBV epitranscriptome reprogramming by METTL14 is critical for viral-associated tumorigenesis
por: Lang, Fengchao, et al.
Publicado: (2019)

Fenofibrate Suppresses Oral Tumorigenesis via Reprogramming Metabolic Processes: Potential Drug Repurposing for Oral Cancer
por: Jan, Chia-Ing, et al.
Publicado: (2016)

The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis
por: Pomerantz, Mark M., et al.
Publicado: (2015)

Multilevel regulation of N(6)-methyladenosine RNA modifications: Implications in tumorigenesis and therapeutic opportunities
por: Feng, Lili, et al.
Publicado: (2022)

Implication of Heat Shock Factors in Tumorigenesis: Therapeutical Potential
por: de Thonel, Aurelie, et al.
Publicado: (2011)

Recent Discoveries of Macromolecule- and Cell-Based Biomarkers and Therapeutic Implications in Breast Cancer
por: Wu, Hsing-Ju, et al.
Publicado: (2021)

Epigenetic Regulation of Breast Cancer Stem Cells Contributing to Carcinogenesis and Therapeutic Implications
por: Wu, Hsing-Ju, et al.
Publicado: (2021)

Metabolic reprogramming: a bridge between aging and tumorigenesis
por: Drapela, Stanislav, et al.
Publicado: (2022)

Photoreceptor metabolic reprogramming: current understanding and therapeutic implications
por: Pan, Warren W., et al.
Publicado: (2021)

Concise review: Cancer cell reprogramming and therapeutic implications
por: Xiao, Xue, et al.
Publicado: (2022)

Integrin-Mediated Tumorigenesis and Its Therapeutic Applications
por: Li, Qingling, et al.
Publicado: (2022)

Hypoxic exosomes orchestrate tumorigenesis: molecular mechanisms and therapeutic implications
por: Jafari, Reza, et al.
Publicado: (2020)

Complex Role of Microbiome in Pancreatic Tumorigenesis: Potential Therapeutic Implications
por: Amara, Suneetha, et al.
Publicado: (2022)

The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis
por: Aldiri, Issam, et al.
Publicado: (2017)

Serine Metabolic Reprogramming in Tumorigenesis, Tumor Immunity, and Clinical Treatment
por: Shunxi, Wang, et al.
Publicado: (2023)

Targeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma
por: Chen, Chang-Yu, et al.
Publicado: (2015)

Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming
por: Suryo Rahmanto, Yohan, et al.
Publicado: (2020)

Pathogenesis and Potential Therapeutic Targets for Triple-Negative Breast Cancer
por: Li, Chia-Jung, et al.
Publicado: (2021)

BMP signaling and its paradoxical effects in tumorigenesis and dissemination
por: Zhang, Lijie, et al.
Publicado: (2016)

Fusobacterium nucleatum-triggered purine metabolic reprogramming drives tumorigenesis in head and neck carcinoma
por: Li, Feiran, et al.
Publicado: (2023)

G protein-coupled kisspeptin receptor induces metabolic reprograming and tumorigenesis in estrogen receptor-negative breast cancer
por: Dragan, Magdalena, et al.
Publicado: (2020)

Common Telomere Changes during In Vivo Reprogramming and Early Stages of Tumorigenesis
por: Marión, Rosa M., et al.
Publicado: (2017)

The TRPM7 channel reprograms cellular glycolysis to drive tumorigenesis and angiogenesis
por: Wu, Wanzhou, et al.
Publicado: (2023)

Monocytes reprogrammed by tumor microparticle vaccine inhibit tumorigenesis and tumor development
por: Sun, Weiwei, et al.
Publicado: (2023)

Increasing CD44(+)/CD24(- )tumor stem cells, and upregulation of COX-2 and HDAC6, as major functions of HER2 in breast tumorigenesis
por: Wang, Kai-Hung, et al.
Publicado: (2010)

Tumor Cell‐Intrinsic SETD2 Deficiency Reprograms Neutrophils to Foster Immune Escape in Pancreatic Tumorigenesis
por: Niu, Ningning, et al.
Publicado: (2022)

Central Role of CEMIP in Tumorigenesis and Its Potential as Therapeutic Target
por: Li, Li, et al.
Publicado: (2017)

Metabolic Reprogramming by Ribitol Expands the Therapeutic Window of BETi JQ1 against Breast Cancer
por: Doddapaneni, Ravi, et al.
Publicado: (2023)

Lung cancer-associated mesenchymal stem cells promote tumor metastasis and tumorigenesis by induction of epithelial–mesenchymal transition and stem-like reprogram
por: Yan, Cihui, et al.
Publicado: (2021)

Niche Modulation of IGF-1R Signaling: Its Role in Stem Cell Pluripotency, Cancer Reprogramming, and Therapeutic Applications
por: Chen, Pei-Chin, et al.
Publicado: (2021)

Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications
por: Xiao, Nan, et al.
Publicado: (2021)

LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases
por: Zhang, Yanghe, et al.
Publicado: (2020)

PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism
por: Dai, Weixing, et al.
Publicado: (2022)

Pituitary Tumorigenesis—Implications for Management
por: Vamvoukaki, Rodanthi, et al.
Publicado: (2023)

Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications
por: Wu, Hsing-Ju, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0608n52p3qdv8vkghkcbjmupqe